Title : CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships.

Pub. Date : 1993 Oct 15

PMID : 8274578






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Diazepam-binding inhibitor (DBI) is a 9-kD neuropeptide that interacts with the benzodiazepine (BZD) binding sites of the neuronal gamma-aminobutyric acid type A (GABAA) receptor and with the glial mitochondrial BZD receptor (MBR). Benzodiazepines diazepam binding inhibitor, acyl-CoA binding protein Homo sapiens
2 Diazepam-binding inhibitor (DBI) is a 9-kD neuropeptide that interacts with the benzodiazepine (BZD) binding sites of the neuronal gamma-aminobutyric acid type A (GABAA) receptor and with the glial mitochondrial BZD receptor (MBR). Benzodiazepines diazepam binding inhibitor, acyl-CoA binding protein Homo sapiens
3 Diazepam-binding inhibitor (DBI) is a 9-kD neuropeptide that interacts with the benzodiazepine (BZD) binding sites of the neuronal gamma-aminobutyric acid type A (GABAA) receptor and with the glial mitochondrial BZD receptor (MBR). Benzodiazepines diazepam binding inhibitor, acyl-CoA binding protein Homo sapiens
4 Diazepam-binding inhibitor (DBI) is a 9-kD neuropeptide that interacts with the benzodiazepine (BZD) binding sites of the neuronal gamma-aminobutyric acid type A (GABAA) receptor and with the glial mitochondrial BZD receptor (MBR). Benzodiazepines diazepam binding inhibitor, acyl-CoA binding protein Homo sapiens